Publications by authors named "Lothar Mueller"

Claim this Profile
P
Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic colorectal cancer: Subgroup analysis of patients treated within the PanaMa trial (AIO KRK 0212).
Greta Sommerhäuser, Meinolf Karthaus, Annika Kurreck, Alexej Ballhausen, Johanna W Meyer-Knees, Lothar Mueller

Int J Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells-The DETECT III Clinical Trial.
Tanja Fehm, Volkmar Mueller, Maggie Banys-Paluchowski, Peter A Fasching, Thomas W P Friedl, Lothar Mueller

Clin Chem· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fast and label-free automated detection of microsatellite status in early colon cancer using artificial intelligence integrated infrared imaging.
Klaus Gerwert, Stephanie Schörner, Frederik Großerueschkamp, Anna-Lena Kraeft, David Schuhmacher, Lothar Mueller

Eur J Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depth of response of induction therapy and consecutive maintenance treatment in patients with RAS wild-type metastatic colorectal cancer: An analysis of the PanaMa trial (AIO KRK 0212).
Greta Sommerhäuser, Annika Kurreck, Alexander Beck, Uli Fehrenbach, Meinolf Karthaus, Lothar Mueller

Eur J Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causes of mortality in elderly UICC stage III colon cancer (CC) patients--Tumor-related death and competing risks from the German AIO colorectal study group Colopredict Plus (CPP) registry.
Stefanie Nöpel-Dünnebacke, Hendrick Jütte, Robin Denz, Inke Sabine Feder, Anna-Lena Kraeft, Lothar Mueller

Cancer Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High microsatellite instability (MSI-H) is associated with distinct clinical and molecular characteristics and an improved survival in early Colon cancer (CC); real world data from the AIO molecular registry Colopredict Plus.
Stefanie Noepel-Duennebacke, Hendrik Juette, Inke Sabine Feder, Larissa Kluxen, Nadezda Basara, Lothar Mueller

Z Gastroenterol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised phase II trial of trofosfamide vs. doxorubicin in elderly patients with untreated metastatic soft-tissue sarcoma.
Joerg T Hartmann, Hans-G Kopp, Viktor Gruenwald, Sophie Piperno-Neumann, Annegret Kunitz, Lothar Mueller

Eur J Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group.
Anna Dorothea Wagner, Heike I Grabsch, Murielle Mauer, Sandrine Marreaud, Carmela Caballero, Lothar Mueller

BMC Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical Practice.
Martin Wilhelm, Lothar Mueller, M Craig Miller, Karin Link, Stefan Holdenrieder

Clin Colorectal Cancer· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial.
Mathias Rummel, Ulrich Kaiser, Christina Balser, Martina Stauch, Wolfram Brugger, Lothar Mueller

Lancet Oncol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.

Ann Oncol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: a randomized multicenter phase II trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group.
Jalid Sehouli, Dirk Stengel, Philipp Harter, Christian Kurzeder, Antje Belau, Lothar Mueller

J Clin Oncol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A combination of cytomorphology, cytogenetic analysis, fluorescence in situ hybridization and reverse transcriptase polymerase chain reaction for establishing clonality in cases of persisting hypereosinophilia.
Ulrike Bacher, Andreas Reiter, Torsten Haferlach, Lothar Mueller, Susanne Schnittger

Haematologica· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis